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Abstract
Background: The demand for total hip arthroplasty (THA) is quickly rising given the escalating global incidence of
hip osteoarthritis, and it is widely accepted that the post-surgery rehabilitation is key to optimize outcomes. The
overall objective of this study is to evaluate the effectiveness of a new telerehabilitation solution, ReHub, for the
physical function and clinical outcome improvement following THA. The specific aims of this manuscript are to
describe the study design, protocol, content of interventions, and primary and secondary outcomes and to discuss
the clinical rehabilitation impact of the expected experimental results.
Methods/design: This prospective, randomized, controlled, parallel-group trial will include 56 patients who had
undergone primary THA. Patients are randomized to a control group (standard rehabilitation during the 2-week stay
in the rehabilitation clinic followed by 3 weeks of unsupervised home-based rehabilitation) or an experimental
group (standard rehabilitation during the 2-week stay in the rehabilitation clinic followed by 3 weeks of home-
based ReHub-assisted telerehabilitation). The primary outcome is physical performance assessed through the Timed
Up-and-Go (TUG) test. Secondary outcomes include independence level, pain intensity, hip disability, hip range of
motion, muscle strength, and patient’s perception of clinical improvement.
Discussion: Proving the clinical and cost-effectiveness of a home-based telerehabilitation program for physical and
muscle function following THA could support its systematic incorporation in post-surgical rehabilitation protocols,
which should be tailored to the individual and collective needs.
Trial registration: ClinicalTrial.gov NCT04176315. Registered on 22 November 2019
Keywords: Hip dysfunction and Osteoarthritis Outcome Scale, Hip range of motion, Muscle strength, Timed Up-
and-Go test, Total hip arthroplasty
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Background
The demand for total hip arthroplasty (THA) is quickly ris-
ing given the escalating global incidence of hip osteoarth-
ritis [1, 2] that is related both to the aging population and
to the increases in obesity and sedentary behavior [2, 3].
The efficacy of THA is well documented, and it is widely
accepted that the post-surgery rehabilitation is key to
optimize outcomes [4, 5], in particular when the rehabilita-
tion is based on intensive and early progressive exercises
[6], which lead to improved clinical outcomes and patient
satisfaction, and reduction of complications and expenses.
In the face of rapidly increasing health care costs, ensuring
widespread cost-effective rehabilitation became a priority.
In recent years, novel telerehabilitation solutions (i.e., re-
habilitation services delivered at home from a remote loca-
tion through a telecommunication system and information
technology) [7, 8] have been developed that allow profes-
sionals to remotely monitor rehabilitation programs, thereby
improving patient adherence to rehabilitation programs and
reducing the healthcare costs. Recent studies have provided
preliminary evidences that a telerehabilitation program is as-
sociated with better clinical outcomes than conventional re-
habilitation after THA. In fact, Karlon et al. [9] found that a
6-week telerehabilitation program based on video clips of
common exercises (3 sessions/week) added to physical ther-
apy sessions (3 sessions/week) was more effective for the re-
covery of physical function compared to conventional
rehabilitation (physical therapy sessions plus home-based
booklet-guided rehabilitation program). In a very recent
study, Dias Correia et al. [10] also showed that an 8-week
telerehabilitation program (30min/day of exercise per-
formed with a digital biofeedback system, 5–7 sessions/
week) was associated with better outcomes than conven-
tional rehabilitation (1 h/day of a home-based program pro-
vided by a physiotherapist, 3 sessions/week).
The usual rehabilitation settings and care path after
THA in Italy consist of a short (2–3 weeks) stay in a re-
habilitation clinic followed by home-based rehabilitation.
The unsupervised execution of a home-based rehabilita-
tion program implies that patients are individually
charged with the responsibility to undertake exercises at
a time and a place convenient to their needs and daily
living schedules. However, low personal motivation and
misunderstanding the instructions to execute the pro-
gram can negatively affect the outcome of individual
rehabilitation programs. Therefore, it has been sug-
gested that patient supervision may be a key factor to
achieve the best possible rehabilitation results in some
populations [11].
We hypothesized that a home-based telerehabilitation
program performed through the remote supervision of
the patient’s performance and adherence can improve
clinical outcomes compared to conventional (unsuper-
vised) home-based care.
Therefore, the overall objective of this study is to
evaluate the effectiveness of a new telerehabilitation so-
lution, ReHub, for the physical function and clinical out-
come improvement following THA. The specific aims of
this manuscript are to describe the study design, proto-
col, content of interventions, and primary and secondary
outcomes and to discuss the clinical rehabilitation im-
pact of the expected experimental results.
Methods
Study design and randomization
The study is a prospective, randomized, controlled,
parallel-group, open-label with blinded assessor trial that
is conducted according to the SPIRIT recommendations
[12]. Following informed consent, patients are random-
ized (with a 1:1 allocation ratio) to a control group or an
experimental group (Fig. 1). Computer-generated
randomization lists are used (using the website www.
random.org) to sequentially distribute the patients into
one of the two groups. Generation of the allocation se-
quence and assignment of participants to interventions
are performed by one of the authors (MDM).
The study conforms to the guidelines of the Declaration of
Helsinki, was approved by the local ethics committee
(“Comitato Etico Interaziendale AOU Città della Salute e
della Scienza di Torino”: protocol n. 0107065), and registered
at the ClinicalTrial.gov website (identifier NCT04176315).
Study setting and patients
The study setting is a rehabilitation clinic where patients of
both genders who had undergone primary THA surgery
are recruited. The inclusion criteria are as follows: (i) ability
to understand and accept the study procedures and to sign
an informed consent form, (ii) good familiarity with the
Italian language, (iii) good predisposition to the use of tech-
nology or availability of a caregiver providing technological
support to the patient, and (iv) availability to move to the
rehabilitation clinic for a final visit. The exclusion criteria
are as follows: (i) age < 60 or > 80 years and body mass
index > 35 kg/m2; (ii) admission after THA revision surgery;
(iii) contralateral hip osteoarthritis severely limiting patient
mobility and ability to comply with a rehabilitation pro-
gram; (iv) aphasia, dementia, or psychiatric comorbidity
interfering with communication or adherence to the
rehabilitation process; (v) respiratory, cardiac, metabolic, or
other conditions limiting patient mobility and ability to
comply with a rehabilitation program; and (vi) major med-
ical complications occurring after surgery that prevented
the discharge of the patient within 10 days after the surgery.
Interventions
Patients in both groups receive a standard rehabilitation
protocol during the 2-week stay in the rehabilitation
clinic, as directed by the medical staff, aimed to improve
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the hip range of motion (ROM), the global neuromuscu-
lar performance (walking, chair rise, etc.), and the
strength of the hip and lower leg muscles. The program
consists of 3 h/day of physiotherapy during weekdays
(between Monday and Friday) and 1 h of activity on Sat-
urday for a total of 16 h of activity per week.
In addition, patients in the experimental group per-
form also 1–2 sessions per week (2–4 sessions in total)
of supervised familiarization with the ReHub telerehabil-
itation system (see below). Patients in the control group
perform 1–2 sessions per week (2–4 sessions in total) of
supervised familiarization with a printed guide describ-
ing the exercises to be performed at home (Fig. 1).
After discharge from the rehabilitation clinic, patients
in the control group follow the standard home-based
care (they receive a guide to performing the exercises,
and they are asked to fill out a diary questionnaire de-
signed to assess the adherence to the rehabilitation pro-
gram), while patients in the experimental group follow a
home-based telerehabilitation and telemonitoring pro-
gram by using ReHub.
The home-based rehabilitation program consists in the
execution (unsupervised for the control patients, ReHub-
assisted for the experimental patients) of the following 5
exercises: (1) hip flexors, with a lateral support, flexion of
the hip joint up to a maximum of 90° of ROM while bend-
ing the knee; (2) quadriceps (eccentric contraction), with a
front support, lunge with both legs while bending the
knees; (3) hip abductors, with a front support, abduction
of the hip joint (with both knees extended) until the max-
imum ROM is allowed; (4) hip extensors, with a front sup-
port, extension of the hip joint until the maximum ROM
is allowed; and (5) sit-to-stand, standing up from a chair
and sitting down on it sequentially, with one foot slightly
in front of the other and without the support of the upper
limbs (arms are crossed at the wrists and held against the
chest).
Patients are asked to perform the rehabilitation proto-
col according to the following workload: (i) daily execu-
tion of a single exercise session for 3 weeks, (ii) three
series of ten repetitions for each exercise, and (iii) bilat-
eral execution of exercises 1-3-4.
Fig. 1 Study design diagram
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Concomitant care permitted during the home-based
rehabilitation program includes the use of analgesics,
when needed.
The criteria for discontinuing interventions include partici-
pant requests and intolerance to the rehabilitation program.
Retention of study participants is performed according
to the following strategies: use of a systematic method
for patient contact and appointment scheduling, study
reminders, and emphasizing study benefits.
Provisions for post-trial care will consist of the stand-
ard care within the National Health Service.
Adverse events reporting and harms
Any unfavorable and unintended sign, symptom, or illness
that develops or worsens during the period of the study is
classified as an adverse event, whether or not it is consid-
ered to be related to the study treatment. Adverse events
may include an exacerbation of a pre-existing illness, a
condition that is detected after trial intervention adminis-
tration, and continuous persistent disease or a symptom
present at baseline that worsens following the administra-
tion of the trial treatment—and may be expected or unex-
pected. The number (events and individuals) and the
nature of all adverse events reported to blind and unblind
members of the research team are recorded. The period
for adverse event reporting is following the signing of the
study consent form until the last follow-up assessment.
All adverse events are recorded and reviewed by the chief
investigator (MAM).
Blinding and outcomes
A blinded physician (GC) completes all functional as-
sessments and gathers all clinical data on the electronic
medical record of each patient, as reported in Fig. 2.
The following clinical data are acquired from electronic
patient files and clinical assessments: gender, age, body
mass index, and length of hospital stay.
The primary outcome is physical performance assessed
through the Timed Up-and-Go (TUG) test that measures
the time required for standing up from a chair, walking
straight for 3 m, turning, walking back to the chair, and
sitting down [13].
Secondary outcomes include the following: (i) independ-
ence level (assessed through the Functional Independence
Measure (FIM) scale) [14]; (ii) resting and movement pain
intensity (assessed through a Numerical Rating Scale with
0 corresponding to “no pain” and 100 corresponding to
the “worst imaginable pain”)—resting pain intensity is
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure showing the schedule of enrollment, interventions,
and assessments
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measured prior to any study procedures, while movement
pain is measured during active hip flexion and extension;
(iii) hip disability (assessed through the Hip dysfunction
and Osteoarthritis Outcome Scale (HOOS)) [15]; (iv) hip
ROM and muscle strength (see below); (v) patient’s percep-
tion of clinical improvement (assessed through a 6-point
Likert scale investigating the global rating of change
(GROC): 1 =much worse, 2 = worse, 3 = same, 4 = im-
proved, 5 =much improved, and 6 = completely recovered).
All outcomes are assessed at three points [see Figs. 1
and 2—baseline visit (t1), rehabilitation clinic admission;
follow-up visit (t2), rehabilitation clinic discharge; final
visit (t3), 3 weeks after discharge], with the exception of
the GROC score that is assessed at the final visit only.
Assessment of hip ROM and muscle strength
All ROM tests are conducted (using a manual, plastic, 2-
arm goniometer with 1° increments) by a single physio-
therapist, blinded to the allocation group. Only the pas-
sive ROM of the operated side is assessed in the
following order: flexion, extension, and abduction. Hip
flexion and abduction ROM are measured with partici-
pants in the supine position, while hip extension ROM
is measured in the side-lying position.
The maximal isometric voluntary contraction of the
operated side is assessed using a wall-fixed dynamometer
(model HCB 99 K50, Kern & Sohn, Balingen, Germany).
Muscle strength tests are performed in the following
order: knee extension, hip extension, and hip abduction.
Knee extension is assessed with participants in the sit-
ting position, with both hip and knee at 90° flexion. Hip
extension and hip abduction are measured with partici-
pants in the standing position, with the body weight sup-
ported by the contralateral lower limb, hip in the neutral
position, and knee in the extended position.
ReHub telerehabilitation system
ReHub is a digital platform for physical rehabilitation that
offers personalized design and monitoring of therapeutic
exercise programs to recover the functional capacity of the
musculoskeletal system. The solution is composed of two
main pillars: a cloud platform and a sensorized exercise kit.
The cloud platform establishes effective communication be-
tween the patient and the healthcare professionals in charge
of their rehabilitation. It allows physical therapists to create
a rehabilitation program specifically tailored to each pa-
tient’s condition. Patients use the cloud platform to per-
form the exercises in their rehabilitation program with the
help of DyCare’s proprietary wearable sensor that captures
3D motion data. The sensor is integrated into different ex-
ercise tools, although only a body strap is used in this study
as the selected exercises do not require additional tools.
The sensor records biomechanical parameters (such as
ROM and movement speed) in real-time when used on the
indicated body part while exercising. When patients do
their prescribed exercises at home, intelligent algorithms
deliver real-time biofeedback through a user interface and a
virtual coach. The results can be viewed by the physical
therapist to follow the progress of the patient, adapt the
program remotely if needed, or chat with the patient by on-
line messaging module through the platform.
Sample size estimation and statistical analyses
To elucidate a difference in physical performance be-
tween the intervention and the control groups, we used
data from previous studies (average ± standard deviation
of the TUG score in patients discharged home after
post-surgery rehabilitation of 13 ± 3.5 s and TUG min-
imal detectable change of 2.5 s) [16, 17] to determine the
required sample size. Twenty-five participants per group
will provide adequate power to detect statistically signifi-
cant differences in the TUG score between the two
groups (allocation ratio 1; statistical power 80%; alpha
level 0.05), but 56 patients will be recruited in total an-
ticipating a dropout rate of 10%.
The statistical analysis of the results will be performed by
a blinded expert. The Kolmogorov-Smirnov test will be
adopted to check the normality of data distribution.
Within- and between-group comparisons will be performed
by a two-sample t test or one-way and two-way ANOVA.
The extent of missing data will be explored in the out-
comes, especially the primary outcome. Patterns of missing
data will be explored and predictors of missingness exam-
ined, especially if these vary by intervention. If necessary,
multiple imputation will be used to impute missing data as-
suming the missingness mechanism is missing at random. A
detailed statistical analysis plan will be agreed to before the
end of data entry and before the treatment code is broken.
Data will be expressed as mean ± standard deviation
(normally distributed data) or median and interquartile
range (non-normally distributed data). The threshold for
statistical significance will be set to P = 0.05. All statis-
tical tests will be performed with MATLAB (The Math-
Works, Inc., Natick, MA, USA) software package.
Discussion
The study aims to assess the effectiveness of a home-
based telerehabilitation program for the physical func-
tion and clinical outcome improvement following THA.
The randomized controlled design, blinding of the phys-
ician performing the outcome assessments, and use of
valid tools for the assessment of physical performance and
muscle strength (TUG score and dynamometer-based
measurements of muscle strength under isometric condi-
tions, respectively) are the notable strengths of the study.
Limitations of the study include the absence of specific
investigations (e.g., electromyography, muscle ultrasonog-
raphy) providing possible insights into the neural and
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muscular mechanisms underlying the effects of tele-
rehabilitation in responder patients (or explaining the
non-responder phenotype) and the lack of assessment
of patient satisfaction and preferences providing pos-
sible insights into the treatment attributes considered
most important by the patients [18].
Other study limitations are represented by the short
intervention duration (3 weeks) and the lack of a long-
term follow-up that could help determine whether the
possible improvements in physical function induced by
the telerehabilitation program may produce long-lasting
benefits in physical performance and health.
Notwithstanding these limitations, demonstrating the
effectiveness of a home-based telerehabilitation program
for physical function and/or muscle strength improve-
ment following THA could have relevant implications
for the post-surgical rehabilitation process. In fact, tele-
rehabilitation solutions can facilitate access and adher-
ence to health interventions, reduce health care costs
(associated with supervision, facility provision, and
transport of patients), and contribute also to social dis-
tancing when it becomes necessary as an infection con-
trol action.
In addition, the direct and indirect costs of using the
telerehabilitation system compared with the costs of the
traditional rehabilitation programs commonly adopted
in THA patients will also be assessed.
Therefore, proving the clinical and cost-effectiveness of a
home-based telerehabilitation program for physical and
muscle function following THA could support its systematic
incorporation in post-surgical rehabilitation protocols, which
should be tailored to the individual and collective needs.
Trial findings will be disseminated to the scientific
community through publications and national and inter-
national conferences (authorship and time scales will be
agreed by the Trial Management Group consisting of
the trial manager, administrative staff, chief investigator,
and statistician). Findings will also be disseminated to
participants and patient organizations through social
media and presentations at local conferences.
Trial status
The Trial Management Group meets on a weekly basis to
discuss progress and monitor recruitment, data returns,
and so on.
The Trial Management Group meets also every 6 months
for auditing trial conduct.
The first study participants were recruited into the
trial in December 2019 (study protocol version 1, dated
20 September 2019). Patient recruitment and data col-
lection are ongoing and will continue until the required
number of study participants will be achieved (estimated
date of the recruitment completion: November 2020).
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